ALXA update

6th-Sense

Alexza: CHMP Adopts Positive Opinion on Schizophrenia, Bipolar Drug
1 hours 59 minutes ago - Dow Jones News
By Ben Fox Rubin Alexza Pharmaceuticals Inc. (ALXA) and Grupo Ferrer Internacional SA said the Committee for Medicinal Products for Human Use adopted a positive opinion on recommending European marketing of schizophrenia and bipolar disorder treatment Adasuve, a win for the small drug maker.

----------------------------------------------------------------------------------
Next Friday : FDA decision.......see what will happen....